Skip to main content Accessibility help

Recognizing and treating pseudobulbar affect

  • William M. Sauvé (a1)


Pseudobulbar affect, thought by many to be a relatively newly described condition, is in fact a very old one, described as early as the 19th century. It refers to those who experience inappropriate affect, disconnected from internal state, or mood, generally thought to be the result of an upper motor neuron injury or illness. One possible explanation for this condition’s relative obscurity is the dearth of treatment options; clinical medicine is not typically in the habit of identifying conditions that cannot be modified. Now, however, there is good evidence for the treatment of pseudobulbar affect, and even a therapy approved for use by the U.S. Food and Drug Administration (FDA). As a result, appropriate identification and subsequent management of pseudobulbar affect is more important than ever. This article purports to summarize the origins of pseudobulbar affect, most current hypotheses as to its physiopathology, clinical identification, and evidence for management.


Corresponding author

*Address for correspondence: William Sauvé, MD, Greenbrook TMS Neurohealth Centers, 100 Eastshore Dr., Glen Allen, VA 23059, USA. (Email:


Hide All

This activity is supported by an unrestricted educational grant from Avanir Pharmaceuticals.



Hide All
1. Schiffer, R, Pope, LE. Review of pseudobulbar affect including a novel and potential therapy. J Neuropsychiatry Clin Neurosci. 2005; 17(4): 447454.
2. Marie, P. Leçons Sur Les Maladies De La Moelle. Paris: G. Masson; 1892.
3. Heathfield, KW, Jewesbury, EC. Supranuclear bulbar palsy (pseudobulbar palsy) in mitral stenosis. Br Med J. 1950; 2(4690): 11961198.
4. Parvizi, J, Coburn, KL, Shillcutt, SD, Coffey, CE, Lauterbach, EC, Mendez, MF. Neuroanatomy of pathological laughing and crying: a report of the American Neuropsychiatric Association Committee on Research. J Neuropsychiatry Clin Neurosci. 2009; 21(1): 7587.
5. Miller, A, Pratt, H, Schiffer, RB. Pseudobulbar affect: the spectrum of clinical presentations, etiologies and treatments. Expert Rev Neurother. 2011; 11(7): 10771088.
6. Wang, G, Teng, F, Chen, Y, et al. Clinical features and related factors of poststroke pathological laughing and crying: a case-control study. J Stroke Cerebrovasc Dis. 2016; 25(3): 556564.
7. Min, WY, Khare, CB. Chemotherapy-induced pseudobulbar affect: a novel case. J Neuropsychiatry Clin Neurosci. 2013; 25(4): E11E13.
8. Pollack, IF, Polinko, P, Albright, AL, Towbin, R, Fitz, C. Mutism and pseudobulbar symptoms after resection of posterior fossa tumors in children: incidence and pathophysiology. Neurosurgery. 1995; 37(5): 885893.
9. Floeter, MK, Katipally, R, Kim, MP, et al. Impaired corticopontocerebellar tracts underlie pseudobulbar affect in motor neuron disorders. Neurology. 2014; 83(7): 620627.
10. Li, Z, Luo, S, Ou, J, Huang, R, Wang, Y. Persistent pseudobulbar affect secondary to acute disseminated encephalomyelitis. Socioaffect Neurosci Psychol. 2015; 5: 26210.
11. Brooks, BR, Crumpacker, D, Fellus, J, Kantor, D, Kaye, RE. PRISM: a novel research tool to assess the prevalence of pseudobulbar affect symptoms across neurological conditions. PloS One. 2013; 8(8): e72232.
12. Fonda, JR, Hunt, PR, McGlinchey, RE, et al. Identification of pseudobulbar affect symptoms in veterans with possible traumatic brain injury. J Rehabil Res Dev. 2015; 52(7): 839849.
13. Poeck, K. Pathophysiology of emotional disorders associated with brain damage. Handb Clin Neurol. eds. Vinken P and Bruyn G. New York: American Elsevier Publishing Company, 1969; 3: 343367.
14. Cummings, JL, Arciniegas, DB, Brooks, BR, et al. Defining and diagnosing involuntary emotional expression disorder. CNS Spectr. 2006; 11(6): 17.
15. Robinson, RG, Parikh, RM, Lipsey, JR, Starkstein, SE, Price, TR. Pathological laughing and crying following stroke: validation of a measurement scale and a double-blind treatment study. Am J Psychiatry. 1993; 150(2): 286293.
16. Engelman, W, Hammond, FM, Malec, JF. Diagnosing pseudobulbar affect in traumatic brain injury. Neuropsychiatr Dis Treat. 2014; 10: 19031910.
17. Iacovides, A, Andreoulakis, E. Bipolar disorder and resembling special psychopathological manifestations in multiple sclerosis: a review. Curr Opin Psychiatry. 2011; 24(4): 336340.
18. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Health Disorders. 5th ed. Washington, DC: American Psychiatric Publishing; 2013.
19. Rottenberg, J, Cevaal, A, Vingerhoets, AJ. Do mood disorders alter crying? A pilot investigation. Depress Anxiety. 2008; 25(5): E915.
20. Rottenberg, J, Gross, JJ, Wilhelm, FH, Najmi, S, Gotlib, IH. Crying threshold and intensity in major depressive disorder. J Abnorm Psychol. 2002; 111(2): 302312.
21. Schwab, KA, Ivins, B, Cramer, G, et al. Screening for traumatic brain injury in troops returning from deployment in Afghanistan and Iraq: initial investigation of the usefulness of a short screening tool for traumatic brain injury. J Head Trauma Rehabil. 2007; 22(6): 377389.
22. Smith, RA, Berg, JE, Pope, LE, Callahan, JD, Wynn, D, Thisted, RA. Validation of the CNS emotional lability scale for pseudobulbar affect (pathological laughing and crying) in multiple sclerosis patients. Mult Scler. 2004; 10(6): 679685.
23. Colamonico, J, Formella, A, Bradley, W. Pseudobulbar affect: burden of illness in the USA. Adv Ther. 2012; 29(9): 775798.
24. Thakore, NJ, Pioro, EP. Depression in ALS in a large self-reporting cohort. Neurology. 2016; 86(11): 10311038.
25. Rudolph, JL, Fonda, JR, Hunt, PR, et al. Association of pseudobulbar affect symptoms with quality of life and healthcare costs in veterans with traumatic brain injury. J Affect Disord. 2016; 190: 150155.
26. Okuda, DT, Chyung, AS, Chin, CT, Waubant, E. Acute pathological laughter. Mov Disord. 2005; 20(10): 13891390.
27. Perotti, LP, Cummings, LD, Mercado, J. Behavioral treatment of pseudobulbar affect: a case report. Perspect Psychiatr Care. 2016; 52(2): 8287.
28. Fonda, JR, McGlinchey, RE, Rudolph, JL, et al. Screening for PBA symptoms using a single question versus a 7 question measure and assessment of the association of PBA symptoms with HRQOL burden. Value Health. 2014; 17(3): A64.
Recommend this journal

Email your librarian or administrator to recommend adding this journal to your organisation's collection.

CNS Spectrums
  • ISSN: 1092-8529
  • EISSN: 2165-6509
  • URL: /core/journals/cns-spectrums
Please enter your name
Please enter a valid email address
Who would you like to send this to? *



Full text views

Total number of HTML views: 0
Total number of PDF views: 0 *
Loading metrics...

Abstract views

Total abstract views: 0 *
Loading metrics...

* Views captured on Cambridge Core between <date>. This data will be updated every 24 hours.

Usage data cannot currently be displayed